ARYLCYCLOPROPYLAMIN-BASEREREDE DEMETHYLASEINHIBITORER AF LSD1 OG DERES MEDICINSKE ANVENDELSE

The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g ., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.

Saved in:
Bibliographic Details
Main Authors FYFE, Matthew, Colin, Thor, ORTEGA MUÑOZ, Alberto, TIRAPU FERNANDEZ DE LA CUESTA, Iñigo, MARTINELL PEDEMONTE, Marc, ESTIARTE-MARTÍNEZ, Maria de los Ángeles
Format Patent
LanguageDanish
Published 14.06.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g ., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.
Bibliography:Application Number: DK20110749119T